Gam Holding Ag Bluebird Bio, Inc. Transaction History

Gam Holding Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$27.5 - $37.92 $808,500 - $1.11 Million	-29,400 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$27.12 - $45.97 $546,766 - $926,801	-20,161 Reduced 40.68%	29,400 $1.8 Million
Q1 2019 May 10, 2019	BUY	$64.44 - $104.11 $1.3 Million - $2.1 Million	20,161 Added 68.57%	49,561 $7.8 Million
Q4 2018 Feb 08, 2019	SELL	$59.1 - $93.26 $809,670 - $1.28 Million	-13,700 Reduced 31.79%	29,400 $2.92 Million
Q3 2018 Nov 13, 2018	BUY	$88.86 - $117.49 $657,564 - $869,426	7,400 Added 20.73%	43,100 $6.29 Million
Q1 2018 May 15, 2018	BUY	$105.8 - $150.94 $380,880 - $543,384	3,600 Added 11.21%	35,700 $6.1 Million
Q4 2017 Feb 14, 2018	SELL	$81.25 - $130.7 $593,125 - $954,109	-7,300 Reduced 18.53%	32,100 $5.72 Million
Q3 2017 Nov 14, 2017	BUY	$57.74 - $91.42 $490,790 - $777,070	8,500 Added 27.51%	39,400 $5.41 Million
Q2 2017 Aug 07, 2017	BUY	N/A	30,900	30,900 $3.25 Million

144

63.2M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $644M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.